CLINICAL TRIALS PROFILE FOR ONPATTRO
✉ Email this page to a colleague
All Clinical Trials for ONPATTRO
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT05023889 ↗ | Spectrum of Peripheral and Autonomic Neuropathies in Patients With wtATTR Amyloidosis and Response to Patisiran Therapy" | Not yet recruiting | Alnylam Pharmaceuticals | Early Phase 1 | 2021-10-01 | To evaluate the efficacy and safety of patisiran in patients with wtATTR amyloidosis and symptomatic polyneuropathy by evaluating the effect on neurologic impairment and quality of life. |
NCT05023889 ↗ | Spectrum of Peripheral and Autonomic Neuropathies in Patients With wtATTR Amyloidosis and Response to Patisiran Therapy" | Not yet recruiting | Austin Neuromuscular Center | Early Phase 1 | 2021-10-01 | To evaluate the efficacy and safety of patisiran in patients with wtATTR amyloidosis and symptomatic polyneuropathy by evaluating the effect on neurologic impairment and quality of life. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ONPATTRO
Condition Name
Clinical Trial Progress for ONPATTRO
Clinical Trial Phase
Clinical Trial Sponsors for ONPATTRO
Sponsor Name